Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rapid Oxygen
AddedFeb 15, 2024
UpdatedJun 18, 2026
Rapid Oxygen

Rapid Oxygen

Series A

Rapid Oxygen: Medtech firm offering FDA-cleared, portable, non-explosive oxygen devices for emergencies.

HQ
Stamford, CT, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to make emergency oxygen accessible and safe for everyone, Rapid Oxygen is a medtech company that produces the R15, a patented portable oxygen device. Designed in collaboration with the University of Michigan, the R15 provides 100% oxygen for airway and cardiac emergencies and can be operated by any Good Samaritan without prior training or certification. The device is non-explosive and portable, making it permissible in public areas where traditional oxygen cylinders are restricted by law. The R15 is FDA-cleared, ensuring its reliability and safety in critical situations.

Rapid Oxygen has garnered attention from notable investors and medical professionals who recognize the life-saving potential of its technology. The company's key achievements include FDA clearance for the R15 and successful market penetration in both public and private sectors. By providing a reliable, easy-to-use oxygen solution, Rapid Oxygen has significantly impacted emergency medical response, potentially saving countless lives by making oxygen readily available in situations where every second counts.

Rapid Oxygen - Similar Companies

Aeronics logo

Aeronics

Respirogen logo

Respirogen

respirogen.com

Raydiant Oximetry logo

Raydiant Oximetry

Inogen logo

Inogen

Emergent Respiratory logo

Emergent Respiratory

eresp.com

Oxygen4Life logo

Oxygen4Life

oxygen4life.com

Rapidpulse logo

Rapidpulse

rapidpulsemed.com

GO² Devices logo

GO² Devices

go2devices.com

Aero Therapeutics logo

Aero Therapeutics

Compact Medical logo

Compact Medical

Lean Med logo

Lean Med

Emergency Medical Innovation logo

Emergency Medical Innovation

PremieBreathe logo

PremieBreathe

AccuBreath logo

AccuBreath

accubreath.com

ClearLine MD logo

ClearLine MD

Rapid Oxygen - Quick Facts

Who are Rapid Oxygen's competitors?

Companies similar to Rapid Oxygen include Aeronics, Respirogen, Raydiant Oximetry and Inogen.

When was Rapid Oxygen founded?

Rapid Oxygen was founded in 2016.

Where is Rapid Oxygen's headquarters located?

Rapid Oxygen's headquarters is located in Stamford, CT, US.

When was Rapid Oxygen's last funding round?

Rapid Oxygen's most recent funding round was for $3.5M (USD) in June 2018.

How much has Rapid Oxygen raised to-date?

As of Jun 14, 2018, Rapid Oxygen has raised a total of $5.5M (USD).

How many employees does Rapid Oxygen have?

Rapid Oxygen has 75 employees as of Feb 5, 2024.

Rapid Oxygen - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Medical Devices
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified